A study to assess the safety and efficacy of AZD7789 in participants with advanced or metastatic solid cancer

Trial Identifier: D9570C00001
Sponsor: AstraZeneca
NCTID:: NCT04931654
Start Date: September 2021
Primary Completion Date: January 2025
Study Completion Date: June 2025
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CA, ON Toronto, ON, CA, M5G 2M9
CN Beijing, CN, 100142
CN Guangzhou, CN, 510060
ES Barcelona, ES, 08035
ES Madrid, ES, 28027
FR Bordeaux, FR, 33076
FR Villejuif Cedex, FR, 94805
JP Chuo-ku, JP, 104-0045
JP Kashiwa, JP, 277-8577
NL Amsterdam, NL, 1066 CX
US, GA Atlanta, GA, US, 30322
US, NY New York, NY, US, 10029
US, TN Nashville, TN, US, 37203